EGM
ACRS icon

Engineers Gate Manager’s Aclaris Therapeutics ACRS Stock Holding History

Engineers Gate Manager’s Portfolio ACRS Stock Details ACRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-18,294
Closed -$68.6K – 2200
2026
Q1 		$68.6K Buy
+18,294
New +$61.7K ﹤0.01% 2064
2025
Q4 		– Sell
-17,844
Closed -$33.9K – 2056
2025
Q3 		$33.9K Buy
17,844
+255
+1% +$445 ﹤0.01% 2085
2025
Q2 		$25K Sell
17,589
-22,653
-56% -$30.7K ﹤0.01% 2089
2025
Q1 		$61.6K Sell
40,242
-53,305
-57% -$114K ﹤0.01% 2036
2024
Q4 		$232K Buy
93,547
+54,753
+141% +$136K ﹤0.01% 1835
2024
Q3 		$44.6K Sell
38,794
-21,742
-36% -$26.7K ﹤0.01% 1988
2024
Q2 		$66.6K Buy
60,536
+3,398
+6% +$3.99K ﹤0.01% 1788
2024
Q1 		$70.9K Sell
57,138
-22,651
-28% -$27K ﹤0.01% 1779
2023
Q4 		$83.8K Buy
79,789
+54,319
+213% +$166K ﹤0.01% 1799
2023
Q3 		$174K Buy
+25,470
New +$218K 0.01% 1518
2023
Q2 		– Sell
-21,725
Closed -$176K – 1695
2023
Q1 		$176K Buy
+21,725
New +$276K 0.01% 1451
2022
Q1 		– Sell
-27,453
Closed -$399K – 1795
2021
Q4 		$399K Buy
+27,453
New +$416K 0.02% 1216
2021
Q3 		– Sell
-24,532
Closed -$431K – 1591
2021
Q2 		$431K Buy
24,532
+3,530
+17% +$80.2K 0.03% 922
2021
Q1 		$529K Buy
21,002
+7,095
+51% +$139K 0.03% 960
2020
Q4 		$90K Buy
+13,907
New +$58.7K ﹤0.01% 1594

Other funds holding ACRS

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return

Engineers Gate Manager's ACRS Position: Q2 2026 in Review

Engineers Gate Manager sold out of Aclaris Therapeutics (ACRS) in Q2 2026, closing a stake of 18,294 shares — an estimated $68.6K sold.

Engineers Gate Manager first reported a position in ACRS in Q4 2020 and held it in 15 quarters. The position peaked at $529K in Q1 2021. 149 funds tracked by Wall St. Rank hold ACRS as of Q2 2026.

  • Engineers Gate Manager reported no remaining Aclaris Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Engineers Gate Manager sold 18,294 Aclaris Therapeutics shares in Q2 2026, an estimated $68.6K.
  • Engineers Gate Manager first reported a position in Aclaris Therapeutics in Q4 2020 and held it in 15 quarters.
  • Engineers Gate Manager's Aclaris Therapeutics position peaked at $529K in Q1 2021.
  • 149 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.